Skip to main content

White paper

Four myths: Carving out specialty pharmacy

Integrated specialty pharmacy means better care, lower cost.

Better Together

Plan sponsors are considering different variations of separating specialty pharmacy from the pharmacy benefit manager (PBM). This may take the form of excluding certain drugs from the formulary, or even removing the specialty pharmacy function altogether. In this white paper, we address the four myths of these carve-out approaches and the impact they have:

  • Myth #1: Plan sponsors can better manage utilization with a specialty carve-out.
  • Myth #2: Patients receive equally good pharmacy care when specialty is carved out.
  • Myth #3: Specialty carve-out vendors offer a seamless patient experience with white-glove support.
  • Myth #4: Plan sponsors get better economic value with a specialty carve-out.

Related content

Specialty drug prices giving you sticker shock?

See how Specialty Compass defuses exploding drug costs.

A new approach to rising specialty costs

See how contracting with medical providers can reduce drug costs

Alternative funding: Real savings or problems?

See how much "free" drugs will actually cost you.

Learn how we can help solve your challenges